<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04397393</url>
  </required_header>
  <id_info>
    <org_study_id>1910-ABU-090-NE</org_study_id>
    <nct_id>NCT04397393</nct_id>
  </id_info>
  <brief_title>Does Camel Milk Consumption Decrease The Efficacy Of Midazolam For Sedation</brief_title>
  <official_title>Does Camel Milk Consumption Decrease The Efficacy Of Midazolam For Sedation: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IVI Middle East Fertility Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IVI Middle East Fertility Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim is to verify if camel milk consumption has an impact on the amount of
      Midazolam needed to achieve a satisfactory level of sedation for oocyte retrieval, compared
      to patients never having consumed camel milk.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A pilot study will be performed on patients undergoing oocyte retrieval (OPU) for the first
      time, and correlated to camel milk consumption versus never consumed camel milk, as well as
      age, BMI (body mass index), number of follicles at the time of OPU, number of previous OPUs
      in other clinics, previous vaginal delivery, past medical history positive for chemo therapy,
      alcohol consumption, use of prescribed or illicit drugs, or chronic pain medication.

      The main objective is to analyse if the consumption of camel milk, the frequency, or lack
      thereof correlates with the amount of the sedative drug Midazolam needed to achieve an
      acceptable level of sedation in order to estimate the dosage needed in both patient groups
      more adequately, reducing either discomfort felt at a too low an initial dosage, as well as
      avoiding a deeper level of sedation than needed with subsequent prolonged stay in recovery
      and unpleasant feelings of dizziness and drowsiness, potentially requiring antagonizing
      Midazolam by the use of Flumazenil, and reducing overall costs and length of stay in recovery
      and bed occupancy and enhancing patient experience and satisfaction.

      Would this study enable the Investigators to determine further effect of camel milk on other
      drugs used for various other purposes, and lead to a change in dose regimen?
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 30, 2020</start_date>
  <completion_date type="Anticipated">October 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dosage of Midazolam (in mg) needed to achieve satisfactory level of sedation to perform the OPU</measure>
    <time_frame>1 day</time_frame>
    <description>Mean dosage of Midazolam for both groups (Camel milk consumption vs no camel milk consumption</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Anesthesia</condition>
  <condition>IVF</condition>
  <arm_group>
    <arm_group_label>non-camel milk consumption</arm_group_label>
    <description>non-camel milk consumption over life time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>camel milk consumption</arm_group_label>
    <description>camel milk consumption at least once during lifetime, with 2 subgroups of camel milk consumption: once, twice, three times; as well as regularly (daily, once per week, once per month, once per year).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Dosage of Midazolam (in mg) needed to achieve satisfactory level of sedation to perform OPU</description>
    <arm_group_label>camel milk consumption</arm_group_label>
    <arm_group_label>non-camel milk consumption</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        population is defined by all females of Arab origin, booked for oocyte retrieval for the
        first time in our center
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Arab origin

          -  Female 18 -48 years of age

          -  BMI &lt; 37 kg/m2

          -  All ovarian stimulation protocols

        Exclusion Criteria:

          -  Previous oocyte retrieval at our center

          -  Post chemo therapy

          -  Illicit drug use

          -  Chronic pain medication

          -  Medication which is known to increase the activity of liver enzymes

          -  Any alcohol consumption

          -  Previous vaginal delivery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>48 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nils Engelmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVI Middle East Fertility Clinic LLC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barbara Lawrenz, PhD</last_name>
    <phone>+97126528000</phone>
    <phone_ext>1108</phone_ext>
    <email>barbara.lawrenz@ivirma.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shieryl Digma, RN</last_name>
    <phone>+97126528000</phone>
    <phone_ext>1122</phone_ext>
    <email>shieryl.digma@ivirma.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IVI Middle East Fertility Clinic</name>
      <address>
        <city>Abu Dhabi</city>
        <zip>60202</zip>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <contact>
      <last_name>Barbara Lawrenz, PhD</last_name>
      <phone>+97102 652 8000</phone>
      <phone_ext>1108</phone_ext>
      <email>barbara.lawrenz@ivirma.com</email>
    </contact>
    <contact_backup>
      <last_name>Shieryl Digma, RN</last_name>
      <phone>+97102 652 8000</phone>
      <phone_ext>1122</phone_ext>
      <email>shieryl.digma@ivirma.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Arab Emirates</country>
  </location_countries>
  <link>
    <url>http://www.fao.org/3/X6528E/X6528E11.htm</url>
    <description>Gast, M., Mauboisj, L. and Adda, J. Le lait et les produits laitiers en Ahaggar. Centr. Rech. Anthr. Prehist. Ethn. 1969</description>
  </link>
  <link>
    <url>https://www.cabdirect.org/cabdirect/abstract/19581404476</url>
    <description>Yasin, S.A. and Wahid, A. Pakistan camels. A preliminary survey. Agric. Pakist. 8: 289-297, 1957</description>
  </link>
  <link>
    <url>http://www.fao.org/3/X6528E/X6528E11.htm</url>
    <description>Kuchabaev, K.A. Cherepanova, V.P. and Panomarev P.P. Feeding, milk productivity and chemical composition of camel milk. : 58-62, 1972.El-Bahay, 1962</description>
  </link>
  <link>
    <url>http://www.fao.org/3/X6528E/X6528E11.htm</url>
    <description>Kon, S.K. Milk and milk products for human nutrition. FAO Nutrition Serv. 7, p. 6, 1959 (Revised in 1972)., Knoess, K.H. Milk production of the dromedary. In: Camels. IFS Symposium, Sudan. 201-214, 1979</description>
  </link>
  <link>
    <url>http://www.fao.org/3/X6528E/X6528E11.htm</url>
    <description>Dhingra, D.R. The component fatty acid and glycerides of the milk fats of Indian goats and sheep. Biochem. J. 27: 851-859, 1933</description>
  </link>
  <link>
    <url>http://www.fao.org/3/X6528E/X6528E11.htm</url>
    <description>Dhingra, D.R. Fatty acids and glycerides of the milk fat of camels. Biochem. J. 28: 73-78, 1934</description>
  </link>
  <link>
    <url>http://www.fao.org/3/X6528E/X6528E11.htm</url>
    <description>Ohris, S.P. and Joshi, B.K. Composition of camel milk. Indian Vet. J. 38(a): 514-516, 1961; 38(b): 604-606, 1961</description>
  </link>
  <link>
    <url>http://www.fao.org/3/X6528E/X6528E11.htm</url>
    <description>Epstein, H. The origin of the domestic animals of Africa. Vol. 2. New York. Africiana Publ. Corp. Leipzig. Edition Leipzig. 1971</description>
  </link>
  <link>
    <url>https://www.asahq.org/standards-and-guidelines/continuum-of-depth-of-sedation-definition-of-general-anesthesia-and-levels-of-sedationanalgesia</url>
    <description>Continuum of Depth of Sedation: Definition of General Anesthesia and Levels of Sedation/Analgesia</description>
  </link>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 17, 2020</study_first_submitted>
  <study_first_submitted_qc>May 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2020</study_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IVI Middle East Fertility Clinic</investigator_affiliation>
    <investigator_full_name>Nils Engelmann</investigator_full_name>
    <investigator_title>Anesthesia Consultant</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

